News & Updates
Filter by Specialty:

Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC
09 Sep 2022
In patients with metastatic colorectal cancer (mCRC), using trifluridine/tipiracil with bevacizumab is a safe and effective treatment for refractory disease, a recent study has found.
Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC
09 Sep 2022
Nine metabolic biomarkers can detect gastric cancer
09 Sep 2022
byTristan Manalac
Gastric cancer (GC) patients show an altered metabolic profile as compared with healthy individuals, a recent China study has found. A biomarker panel monitoring for nine metabolites can facilitate timely detection of GC.
Nine metabolic biomarkers can detect gastric cancer
09 Sep 2022
Incidence of peptic ulcer disease decreasing globally
04 Sep 2022
Peptic ulcer disease (PUD) is still a major cause of hospitalization across the globe, but PUD-related hospitalizations and mortality have been on the decline in many countries belonging to the Organisation for Economic Co-operation and Development (OECD) across Asia, Europe, Oceania, North America, and Latin America, reports a study.